Are exosomes applied as a serum, an injection, or combined with other hair treatments?
← back to Exosomes
Are exosomes applied as a serum, an injection, or combined with other hair treatments?
In recent years, exosomes have entered the spotlight as a new frontier in regenerative medicine, particularly for treating hair loss. As a cell-derived therapy, exosomes are gaining attention not only for their scientific novelty but also for their versatile applications in clinical and cosmetic dermatology. But one major question remains: are exosomes used alone as a serum, injected directly, or combined with other treatments to fight hair thinning and baldness?
What Are Exosomes and Why Should We Care About Them?
Exosomes are microscopic vesicles released by cells—especially stem cells—that transport proteins, lipids, and genetic information to neighboring or distant cells. This cellular communication system can influence inflammation, tissue regeneration, and even immune responses. In the context of hair loss, exosomes derived from mesenchymal stem cells (MSCs) have been proposed as agents that could stimulate hair follicle regeneration. They may reactivate dormant follicles by improving local blood flow, reducing inflammation, and encouraging the natural growth cycle of hair.
However, many of the claims surrounding exosome efficacy still lack robust evidence, especially in long-term human trials. Even where the idea is plausible from lab and animal studies, real-world clinical outcomes remain difficult to predict due to variability in preparation methods, dosages, and delivery techniques.
Are Exosomes Applied Topically as a Serum? Not as Simple as It Sounds
Exosome-based serums are available on the market and are often marketed for home or clinical topical use. These serums are usually applied after microneedling, a technique that uses fine needles to create micro-wounds in the scalp. This method is believed to enhance exosome penetration by temporarily disrupting the skin barrier. Applying an unapproved biological product to broken skin also carries a risk of infection and contamination. Nonetheless, the effectiveness of topical exosome therapy alone is still questionable. The stratum corneum—the outermost layer of the skin—is a significant barrier. Without microneedling or another form of transdermal assistance, the majority of exosomes in a serum may not reach the hair follicle’s basal structures where they are needed.
Injecting Exosomes into the Scalp: A More Direct Yet Still Experimental Path
Intradermal injection is the delivery method clinics most often describe for hair restoration. Injections allow exosomes to bypass the outer layers of the skin and deliver their contents directly into the dermis, where hair follicles are embedded. We could not verify any controlled human trial of exosome injections for hair loss.
What this means for us, as people considering the treatment, is caution. There is no standard protocol. Clinics may use different exosome sources, carrier solutions, or injection patterns—all of which could affect results.
What Happens When Exosomes Are Combined with Other Therapies?
In many hair loss clinics, exosomes are used alongside other regenerative techniques such as platelet-rich plasma (PRP) and microneedling. These combination therapies are promoted as synergistic, meaning they could potentially work better together than individually. But again, is there enough research to support this?
We could not verify any controlled study showing that adding exosomes to PRP or microneedling improves results. From a practical standpoint, these combined therapies are also more expensive. The added cost pays for a benefit that has not been shown in trials.
Are These Treatments Even Regulated?
The short answer is no—not yet. The U.S. Food and Drug Administration (FDA) has issued several public warnings regarding the use of exosome products outside of approved clinical trials. FDA states that there are no FDA-approved exosome products for any use, and it has reported serious adverse events in patients who received unapproved exosome products (FDA public safety notification, December 2019; consumer alert, July 2020). In a public statement from December 2019, the FDA emphasized that exosomes fall under the category of biological products, which means they must undergo formal testing and obtain investigational approval before being marketed. The agency has expressed concern that many of these treatments are offered without proper oversight, raising issues about product sterility, dosing accuracy, and patient safety. This information is critical. Anyone considering exosome therapy should verify whether the clinic follows FDA investigational guidelines or operates entirely outside of them. The lack of regulation increases the risk of receiving substandard or improperly processed biological material.
What the Science Actually Tells Us
We could not verify any controlled human trial of exosomes for hair loss. The human reports we found are small and uncontrolled, and much of the supporting work is in cells and animals. FDA's December 2019 notification states that exosome products used to treat diseases in people are regulated as drugs and biological products and need FDA review, and it advises patients to ask for the investigational new drug (IND) number of any exosome product offered to them.
Final Take: So, What Do We Really Need to Know?
Exosomes are a promising but still unproven method for hair restoration. They are used topically, through injection, and often in combination with other therapies. There is no reliable evidence that injection, topical use or combination with PRP or microneedling works better than another. However, the science is still early-stage, most studies are small or uncontrolled, and none of the products are FDA-approved. If we’re considering this treatment, it’s crucial to question the source of the exosomes, the provider’s experience, and whether the clinic is participating in regulated trials. Until more high-quality research emerges, exosome therapy should be viewed as experimental.
User Experiences with Exosome Treatments for Hair Loss
In the Tressless community, exosome therapy has attracted growing interest as a potential solution for hair loss, but users’ experiences reveal a wide range of application methods, results, and skepticism. Despite the scientific promise behind exosomes in regenerative medicine, the community remains cautious—primarily due to high costs, variable outcomes, and lack of regulation.
How Are Exosomes Used?
Exosomes are applied in various forms. Some users report receiving them as injections, often combined with microneedling, which is believed to enhance absorption and follicular stimulation. This method is usually performed in clinical settings and is considered one of the more invasive—and expensive—approaches. Other users mention topical formulations, particularly commercial products where exosomes are mixed with actives such as latanoprost, caffeine, cetirizine, melatonin, vitamin D3, and biotin. **These topicals aim to deliver exosomes through the scalp without needles, appealing to those seeking non-invasive options. ** A few users are experimenting with hybrid regimens, combining exosome therapy with standard treatments like minoxidil and finasteride. In one case, a community post said that adding exosomes to a regimen of dutasteride and oral minoxidil increased the regimen's efficacy by 46% at one year; we could not verify the underlying study. This is a single uncontrolled report on an off-label regimen (dutasteride is approved for hair loss only in a few countries, such as South Korea and Japan, and both drugs need a prescriber), so it cannot show that the exosomes caused the change.
Do Exosomes Actually Work?
The general sentiment in the community is mixed. Some individuals post before-and-after pictures and describe modest improvements in hair density or texture, especially when exosomes are combined with microneedling. However, many others report no noticeable change, even after several months. Several users say minoxidil alone did more for them than exosomes, and users frequently express doubts about whether the exosomes are stable, bioactive, or even real in some commercial products. Concerns about cost and lack of FDA oversight are common. The treatments are often marketed at premium prices, with users paying hundreds to thousands of dollars for sessions or serums. Many question the value of such investments given the limited peer-reviewed evidence in humans and the potential for placebo effects.
Some are also wary of scams and hype, noting that the regenerative skincare and haircare markets often exploit buzzwords like “stem cells” and “exosomes” without providing reliable clinical data. The lack of regulation around the manufacturing and storage of exosomes raises concerns about product consistency and efficacy.
References
U.S. Food and Drug Administration. (2019, December 6). Public safety notification on exosome products. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/public-safety-notification-exosome-products
U.S. Food and Drug Administration. (2020, July 22). Consumer alert on regenerative medicine products including stem cells and exosomes. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes
U.S. Food and Drug Administration. (2019). Important patient and consumer information about regenerative medicine therapies. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies